A citation-based method for searching scientific literature

Salisa Benjaskulluecha, Atsadang Boonmee, Thitiporn Pattarakankul, Benjawan Wongprom, Jeerameth Klomsing, Tanapat Palaga. Sci Rep 2022
Times Cited: 3







List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Therapeutic targeting of PP2A.
Caitlin M O'Connor, Abbey Perl, Daniel Leonard, Jaya Sangodkar, Goutham Narla. Int J Biochem Cell Biol 2018
96
33

Comparative drug screening in NUT midline carcinoma.
A H Beesley, A Stirnweiss, E Ferrari, R Endersby, M Howlett, T W Failes, G M Arndt, A K Charles, C H Cole, U R Kees. Br J Cancer 2014
37
33


Impaired Neovascularization in Aging.
Clark A Bonham, Britta Kuehlmann, Geoffrey C Gurtner. Adv Wound Care (New Rochelle) 2020
8
33

An allosteric inhibitor of the human Cdc34 ubiquitin-conjugating enzyme.
Derek F Ceccarelli, Xiaojing Tang, Benoit Pelletier, Stephen Orlicky, Weilin Xie, Veronique Plantevin, Dante Neculai, Yang-Chieh Chou, Abiodun Ogunjimi, Abdallah Al-Hakim,[...]. Cell 2011
155
33

PROTAC-induced BET protein degradation as a therapy for castration-resistant prostate cancer.
Kanak Raina, Jing Lu, Yimin Qian, Martha Altieri, Deborah Gordon, Ann Marie K Rossi, Jing Wang, Xin Chen, Hanqing Dong, Kam Siu,[...]. Proc Natl Acad Sci U S A 2016
431
33

Hijacking the E3 Ubiquitin Ligase Cereblon to Efficiently Target BRD4.
Jing Lu, Yimin Qian, Martha Altieri, Hanqing Dong, Jing Wang, Kanak Raina, John Hines, James D Winkler, Andrew P Crew, Kevin Coleman,[...]. Chem Biol 2015
598
33

Lysine methylation of transcription factors in cancer.
Dong Han, Mengxi Huang, Ting Wang, Zhiping Li, Yanyan Chen, Chao Liu, Zengjie Lei, Xiaoyuan Chu. Cell Death Dis 2019
36
33

The flip side of phospho-signalling: Regulation of protein dephosphorylation and the protein phosphatase 2Cs.
Govinal Badiger Bhaskara, Min May Wong, Paul E Verslues. Plant Cell Environ 2019
26
33

Decoding the PTM-switchboard of Notch.
Daniel Antfolk, Christian Antila, Kati Kemppainen, Sebastian K-J Landor, Cecilia Sahlgren. Biochim Biophys Acta Mol Cell Res 2019
17
33

DUB3 deubiquitinates and stabilizes NRF2 in chemotherapy resistance of colorectal cancer.
Qi Zhang, Ze-Yan Zhang, Huan Du, Shang-Ze Li, Rongfu Tu, Yi-Fan Jia, Zhe Zheng, Xue-Min Song, Run-Lei Du, Xiao-Dong Zhang. Cell Death Differ 2019
47
33

Homo-PROTACs: bivalent small-molecule dimerizers of the VHL E3 ubiquitin ligase to induce self-degradation.
Chiara Maniaci, Scott J Hughes, Andrea Testa, Wenzhang Chen, Douglas J Lamont, Sonia Rocha, Dario R Alessi, Roberto Romeo, Alessio Ciulli. Nat Commun 2017
124
33

BRD4 blockage alleviates pathological cardiac hypertrophy through the suppression of fibrosis and inflammation via reducing ROS generation.
Wen Zhu, Ruo-Dai Wu, Yun-Gang Lv, Yu-Meng Liu, Hua Huang, Jun-Qing Xu. Biomed Pharmacother 2020
39
33

Induction of p53 suppresses chronic myeloid leukemia.
Luke F Peterson, Miao-Chia Lo, Yihong Liu, Diane Giannola, Emilija Mitrikeska, Nicholas J Donato, Craig N Johnson, Shaomeng Wang, Jessica Mercer, Moshe Talpaz. Leuk Lymphoma 2017
8
33

The non-canonical functions of HIF prolyl hydroxylases and their dual roles in cancer.
Mengchao Yu, Jie Lun, Hongwei Zhang, Lei Zhu, Gang Zhang, Jing Fang. Int J Biochem Cell Biol 2021
6
33

Dynamics of Prolyl Hydroxylases Levels During Disease Progression in Experimental Colitis.
Hamid A Bakshi, Vijay Mishra, Saurabh Satija, Meenu Mehta, Faruk L Hakkim, Prashant Kesharwani, Kamal Dua, Dinesh K Chellappan, Nitin B Charbe, Garima Shrivastava,[...]. Inflammation 2019
7
33

BRD4 Regulates EZH2 Transcription through Upregulation of C-MYC and Represents a Novel Therapeutic Target in Bladder Cancer.
Xinchao Wu, Dong Liu, Dan Tao, Wei Xiang, Xingyuan Xiao, Miao Wang, Liang Wang, Gang Luo, Yawei Li, Fuqing Zeng,[...]. Mol Cancer Ther 2016
72
33

BRD4 methylation by the methyltransferase SETD6 regulates selective transcription to control mRNA translation.
Zlata Vershinin, Michal Feldman, Thilo Werner, Lital Estrella Weil, Margarita Kublanovsky, Elina Abaev-Schneiderman, Menachem Sklarz, Enid Y N Lam, Khawla Alasad, Sarah Picaud,[...]. Sci Adv 2021
8
33


CK2 inhibitor CX-4945 destabilizes NOTCH1 and synergizes with JQ1 against human T-acute lymphoblastic leukemic cells.
Haiwei Lian, Dun Li, Yun Zhou, Esther Landesman-Bollag, Guanglan Zhang, Nicole M Anderson, Kevin Charles Tang, Justine E Roderick, Michelle A Kelliher, David C Seldin,[...]. Haematologica 2017
13
33

Regulation of Wnt Signaling through Ubiquitination and Deubiquitination in Cancers.
Hong-Beom Park, Ju-Won Kim, Kwang-Hyun Baek. Int J Mol Sci 2020
36
33

PCAF-primed EZH2 acetylation regulates its stability and promotes lung adenocarcinoma progression.
Junhu Wan, Jun Zhan, Shuai Li, Ji Ma, Weizhi Xu, Chang Liu, Xiaowei Xue, Yuping Xie, Weigang Fang, Y Eugene Chin,[...]. Nucleic Acids Res 2015
88
33

Histone Methyltransferase SETDB1: A Common Denominator of Tumorigenesis with Therapeutic Potential.
Dimitrios Strepkos, Mariam Markouli, Alexia Klonou, Athanasios G Papavassiliou, Christina Piperi. Cancer Res 2021
19
33

The role of ubiquitination in tumorigenesis and targeted drug discovery.
Lu Deng, Tong Meng, Lei Chen, Wenyi Wei, Ping Wang. Signal Transduct Target Ther 2020
179
33

The crucial role of protein phosphorylation in cell signaling and its use as targeted therapy (Review).
Fatima Ardito, Michele Giuliani, Donatella Perrone, Giuseppe Troiano, Lorenzo Lo Muzio. Int J Mol Med 2017
439
33

SUMO modification in apoptosis.
Peiyao Li, Huiru Jing, Yanzhe Wang, Lei Yuan, Hui Xiao, Qian Zheng. J Mol Histol 2021
6
33

Protein Ubiquitination Research in Oncology.
J Faktor, M Pjechová, L Hernychová, B Vojtěšek. Klin Onkol 2019
14
33

CDK4/6-dependent activation of DUB3 regulates cancer metastasis through SNAIL1.
Tongzheng Liu, Jia Yu, Min Deng, Yujiao Yin, Haoxing Zhang, Kuntian Luo, Bo Qin, Yunhui Li, Chenming Wu, Tao Ren,[...]. Nat Commun 2017
98
33

Stromal induction of BRD4 phosphorylation Results in Chromatin Remodeling and BET inhibitor Resistance in Colorectal Cancer.
Wenyu Wang, Yen-An Tang, Qian Xiao, Wee Chyan Lee, Bing Cheng, Zhitong Niu, Gokce Oguz, Min Feng, Puay Leng Lee, Baojie Li,[...]. Nat Commun 2021
15
33

Systematically Mitigating the p38α Activity of Triazole-based BET Inhibitors.
Angela S Carlson, Huarui Cui, Anand Divakaran, Jorden A Johnson, Ryan M Brunner, William C K Pomerantz, Joseph J Topczewski. ACS Med Chem Lett 2019
17
33

Bardoxolone conjugation enables targeted protein degradation of BRD4.
Bingqi Tong, Mai Luo, Yi Xie, Jessica N Spradlin, John A Tallarico, Jeffrey M McKenna, Markus Schirle, Thomas J Maimone, Daniel K Nomura. Sci Rep 2020
57
33


Prolyl 4-hydroxylase.
Kelly L Gorres, Ronald T Raines. Crit Rev Biochem Mol Biol 2010
356
33

Role of BRD4 phosphorylation in the nucleus accumbens in relapse to cocaine-seeking behavior in mice.
Wei Guo, Hailei Long, Qian Bu, Yinglan Zhao, Hongbo Wang, Jingwei Tian, Xiaobo Cen. Addict Biol 2020
10
33

BET Bromodomain Proteins as Cancer Therapeutic Targets.
Shaokun Shu, Kornelia Polyak. Cold Spring Harb Symp Quant Biol 2016
45
33

Ubiquitination: Friend and foe in cancer.
Mohammed A Mansour. Int J Biochem Cell Biol 2018
107
33


[Advancesin enrichment and detection methods for N-phosphorylated proteins].
Yechen Hu, Bo Jiang, Lihua Zhang, Yukui Zhang. Se Pu 2020
1
100

Protein Modification and Autophagy Activation.
Rui Wang, Guanghui Wang. Adv Exp Med Biol 2019
28
33

Reactivation of endogenous retroviral elements via treatment with DNMT- and HDAC-inhibitors.
Michael Daskalakis, David Brocks, Yi-Hua Sheng, Md Saiful Islam, Alzbeta Ressnerova, Yassen Assenov, Till Milde, Ina Oehme, Olaf Witt, Ashish Goyal,[...]. Cell Cycle 2018
34
33

BRD4 in physiology and pathology: ''BET'' on its partners.
Yin Liang, Jieyi Tian, Tao Wu. Bioessays 2021
8
33

Prolyl hydroxylase domain enzymes: important regulators of cancer metabolism.
Ming Yang, Huizhong Su, Tomoyoshi Soga, Kamil R Kranc, Patrick J Pollard. Hypoxia (Auckl) 2014
30
33

Combining inhibitors of Brd4 and cyclin-dependent kinase can decrease tumor growth in neuroblastoma with MYCN amplification.
Lauren Wood, Min Huang, Jasmine Zeki, Miao Gong, Jordan Taylor, Hiroyuki Shimada, Bill Chiu. J Pediatr Surg 2021
6
33

PP2A inhibition determines poor outcome and doxorubicin resistance in early breast cancer and its activation shows promising therapeutic effects.
Raúl Rincón, Ion Cristóbal, Sandra Zazo, Oriol Arpí, Silvia Menéndez, Rebeca Manso, Ana Lluch, Pilar Eroles, Ana Rovira, Joan Albanell,[...]. Oncotarget 2015
79
33

PP2A regulates signaling through hormonal receptors in breast cancer with important therapeutic implications.
Ion Cristóbal, Blanca Torrejón, Javier Martínez-Useros, Juan Madoz-Gurpide, Federico Rojo, Jesús García-Foncillas. Biochim Biophys Acta Rev Cancer 2017
9
33

The therapeutic effect of the BRD4-degrading PROTAC A1874 in human colon cancer cells.
An-Cheng Qin, Hua Jin, Yu Song, Yun Gao, Yi-Fan Chen, Li-Na Zhou, Shu-Sheng Wang, Xing-Sheng Lu. Cell Death Dis 2020
12
33

Phospho switch triggers Brd4 chromatin binding and activator recruitment for gene-specific targeting.
Shwu-Yuan Wu, A-Young Lee, Hsien-Tsung Lai, Hong Zhang, Cheng-Ming Chiang. Mol Cell 2013
221
33

BRD4 and Cancer: going beyond transcriptional regulation.
Benedetta Donati, Eugenia Lorenzini, Alessia Ciarrocchi. Mol Cancer 2018
250
33

Pevonedistat (MLN4924): mechanism of cell death induction and therapeutic potential in colorectal cancer.
Jennifer Ferris, Margarita Espona-Fiedler, Claudia Hamilton, Caitriona Holohan, Nyree Crawford, Alex J McIntyre, Jamie Z Roberts, Mark Wappett, Simon S McDade, Daniel B Longley,[...]. Cell Death Discov 2020
10
33

5
33


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.